New research opens the door for the development of treatments capable of stopping Alzheimer’s disease before its first symptoms, that is to say before any crucial damage occurs. In fact, if AD is a devastating disorder, it is also an extremely slow one; it takes more than 10 years for the first symptoms to appear, making this preclinical period the ideal time to intervene.
A group of proteins identified by researchers at Stockholm's KTH Royal Institute of Technology could play a role in helping multiple sclerosis patients get more accurate diagnostics about the severity and progress of their disease. Like other autoimmune diseases, MS is complex and difficult to cure or to mitigate.
Given Imaging Ltd. has announced that the United States Food and Drug Administration (FDA) has granted 510(k) clearance for the next generation PillCam, SB 3, to detect and monitor small bowel abnormalities associated with Crohn's disease, obscure gastrointestinal (GI) bleeding and iron deficiency anemia.
Soaring health care costs across the globe, accompanied by growing demands from aging populations and emerging economies, are fueling technological and business innovation to address an emerging need in an industry worth trillions of dollars, according to Lux Research.
Genome Liberty, a New Jersey-based startup, wants to provide a $99 test that will tell customers, based on their genetics, if they should take a nonstandard dose of a drug because their body will break it down faster or slower than most people. In some cases the test might suggest a particular drug someone should take or avoid.
Vladimir Dreytser, senior staff engineer at Intertek, was a part of the staff written article, “Portability Is the Name of the Game.” He took time to present a full array of responses that were not able to be included in the article, so they are presented here.
Innovative control technology offers medical professionals and technicians the potential to do much more with diagnostic imaging equipment. This article looks at intuitive controls that can be used for radiological applications that offer an interface much closer to familiar consumer devices.
XPRIZE and Nokia today announced the 12 finalist teams for the first competition in the $2.25 million Nokia Sensing XCHALLENGE, two separate and consecutive competitions to advance innovative sensing technologies that capture meaningful data about a consumer’s health and surrounding environment.
Today, a diagnosis is now possible even if the medical professional isn't at their workstation, or even in the hospital at all. In fact, diagnostic images can be securely reviewed over smartphones, tablets, and laptops from any location in the world. The benefits of this flexibility are endless.
Telemedicine consultations with pediatric critical-care medicine physicians significantly improve the quality of care for seriously ill and injured children treated in remote rural emergency rooms, where pediatricians and pediatric specialists are scarce, a study by researchers at UC Davis Children's Hospital has found.
Hospital rooms beep and flash with many devices that are increasingly getting infected with malware. But for several reasons, these gadgets are often incompatible with commercial security software. Now, new technology developed by academic researchers could catch most malware on the devices just by noting subtle changes in their power consumption.
The U.S. Food and Drug Administration today approved the first rapid Human Immunodeficiency Virus (HIV) test for the simultaneous detection of HIV-1 p24 antigen as well as antibodies to both HIV-1 and HIV-2 in human serum, plasma, and venous or fingerstick whole blood specimens.
Tumor cells circulating within a patient's bloodstream can carry cancer from a primary tumor site to distant sites of the body, spreading the disease. Now a team of researchers in China has developed a new microfluidic chip that can quickly and efficiently segregate and capture live circulating tumor cells from a patient's blood, with potential applications for cancer screenings and treatment assessments.
Welcome to the Pulse, brought to you by MDT TV. Today, we're implanting an MRI-safe spinal cord stimulator, sorting blood with a microchip, building robots out of biocompatible hydrogel, and making hydrogel move with light.
You’ve heard of on-demand TV, now imagine on-demand medical diagnosis – anytime, anywhere in the world. Scientists at GE Global Research are working with a team based at the University of Washington to develop a new medical device, the size of a pack of playing cards, that can detect infectious disease by way of a simple nasal swab, in less than an hour.
The Journal of Visualized Experiments has published two new methods for scientists to study and treat tumor growth. The methods introduce a lab-born, human tissue structure with replicated human biochemistry – offering scientists the opportunity to grow, observe, and ultimately learn how to treat biopsied human tumor cells.
Quanterix Corporation, delivering the world’s most sensitive single molecule immunoassay measurement for the benefit of human health, today announced that the Simoa HD-1 Analyzer recently launched by Quanterix uses a “Smart Consumable” designed and manufactured by Sony DADC BioSciences called the Simoa Disc.
Researchers at the Harvard School of Engineering and Applied Sciences (SEAS) have developed a way for photographers and microscopists to create a 3D image through a single lens, without moving the camera. Published in the journal Optics Letters, this improbable-sounding technology relies only on computation and mathematics—no unusual hardware or fancy lenses.
MIT scientists have developed a new microchip that can quickly separate white blood cells from samples of whole blood, eliminating any preliminary processing steps—which can be difficult to integrate into point-of-care medical devices. The hope, the researchers say, is to integrate the microchip into a portable diagnostic device.
Hologic touted a new FDA clearance for its Single Energy Femur Exam, a test for finding rare, unusual femur fractures that pose a high risk to patients. The diagnostic exam is intended for patients that do not respond to bisphosphonates, drugs prescribed to prevent osteoporosis.
Some animals—like the octopus and cuttlefish—transform their shape based on environment, fending off attackers or threats in the wild. For decades, researchers have worked toward mimicking similar biological responses in non-living organisms, as it would have significant implications in the medical arena.
Alere Connect has been granted a 510(k) market clearance by the U.S. FDA for the Alere MobileLink. The new product offering is one of Alere's connected device technologies designed to empower patients by allowing self-testing at home and delivering data quickly and seamlessly to clinical systems accessed by their healthcare providers.
Reaching a clinic in time to receive an early diagnosis for cancer -- when the disease is most treatable -- is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.
A novel interactive 3Dimensional (3D) simulation platform offers surgical residents a unique opportunity to hone their diagnostic and patient management skills, and then have those skills accurately evaluated according to a new study appearing in the August issue of the Journal of the American College of Surgeons.
FDA Clears Hologic's Single Energy Femur Exam to Visualize Features Associated with Developing Atypical Femur Fractures on a DXA PlatformAugust 1, 2013 4:07 pm | by PR Newswire | News | Comments
Hologic announced it received U.S. Food and Drug Administration (FDA) clearance for the Company's Single Energy (SE) Femur Exam on a dual energy x-ray absorptiometry (DXA) platform for the assessment of features associated with atypical femur fractures (AFF).